NCT00045136View on ClinicalTrials.gov

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2003

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

holmium Ho 166 DOTMP

Trial Locations (5)

37212

Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville

95817

University of California Davis Cancer Center, Sacramento

35294-0006

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

Sponsors
All Listed Sponsors
lead

Poniard Pharmaceuticals

INDUSTRY